...
首页> 外文期刊>International journal of gynecological cancer: official journal of the International Gynecological Cancer Society >Attitudes of patients with gynecological and breast cancer toward integration of complementary medicine in cancer care.
【24h】

Attitudes of patients with gynecological and breast cancer toward integration of complementary medicine in cancer care.

机译:妇科和乳腺癌患者对补充药物整合到癌症治疗中的态度。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: The purpose of this study was to explore prospectively the perspectives of patients with breast and gynecological cancers regarding integration of complementary and alternative medicine (CAM) in conventional oncology settings. METHODS: We developed a 27-item questionnaire that was administered to convenient sample of patients with breast cancer and another with gynecological cancer who were attending a community-based oncology service in northern Israel. RESULTS: Of the 275 respondents, 109 (39.6%) had gynecological cancers and 166 (60.4%) had breast cancer. Current and/or previous year CAM use for oncology treatment was significantly higher among the patients with gynecological cancer (73/166 [44%] vs 67/106 [63%], P = 0.03). A logistic regression model indicated that CAM use was associated with gynecological cancer (EXP [B], 2.51; 95% confidence interval for EXP [B], 1.29-4.88; P = 0.007], younger age, Jewish religion, and lesser degree of religiosity. The patients highly expected their gynecologist-oncologist and family doctor to refer them to CAM counseling. Moreover, they expected their gynecologist-oncologist to participate in building a CAM treatment plan if CAM were to be integrated into the oncology service. The patients expected the CAM consultant to inform them of the safety and efficacy of CAM treatments, emphasizing expectations to strengthen their general ability to cope with the disease, reduce chemotherapy side effects, and provide emotional and spiritual support. CONCLUSION: Although patients with gynecological malignancies use CAM significantly more than patients with breast cancer, both groups share similar conceptions regarding the active role of their gynecologist oncologists in the process of CAM integration within supportive care and expect CAM consultation to focus on improving their well-being.
机译:目的:本研究的目的是前瞻性地探讨乳腺癌和妇科癌症患者在传统肿瘤学领域对补充和替代药物(CAM)整合的观点。方法:我们开发了一份27项问卷,用于方便地抽取参加以色列北部社区肿瘤治疗的乳腺癌患者和另一名妇科癌症患者的样本。结果:在275名受访者中,有109名(39.6%)患有妇科癌症,有166名(60.4%)患有乳腺癌。在妇科癌症患者中,当前和/或上一年的CAM用于肿瘤治疗的比例明显更高(73/166 [44%]与67/106 [63%],P = 0.03)。 Logistic回归模型表明,CAM的使用与妇科癌症有关(EXP [B],2.51; EXP [B]的95%置信区间,[B],1.29-4.88; P = 0.007],年龄较小,犹太宗教信仰,而其程度较低。患者高度希望他们的妇科医生和家庭医生将他们推荐给CAM咨询,此外,他们希望他们的妇科医生和肿瘤医生能够参与将CAM纳入肿瘤治疗服务的CAM治疗计划。结论:尽管妇科恶性肿瘤患者大量使用CAM,但CAM顾问应告知他们CAM治疗的安全性和有效性,强调期望增强他们应对疾病,降低化疗副作用以及提供精神和精神支持的一般能力。与乳腺癌患者相比,两组患者对妇科肿瘤学家在治疗中的积极作用有着相似的看法将CAM整合到支持性护理中,并期望CAM咨询能专注于改善他们的健康。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号